PharmaFrontiers' strategy is to develop and commercialize cell therapies to treat several major disease areas including multiple sclerosis, cardiology, and diabetes. The company is commercializing its proprietary stem cell technology -- monocyte-derived adult pluripotent stem cells...
Your Rating
You must submit at least one review.
Review successfully posted.
You will shortly receive an email to confirm your review.
Currently no review was submitted for this company. Share your experiences with this company!